A community for people who want to remain as healthy as possible as we age.

Pharma group urges broader U.S. market approach to Medicare

(Reuters) The role of the U.S. pharmaceutical industry within Medicare should be expanded as a way to reduce the popular healthcare program's contribution to the federal deficit without resorting to drug rebates, the chief of the industry's trade group said on Thursday.
John Castellani, head of the Pharmaceutical Research and Manufacturers of America, or PhRMA, proposed applying elements of the Medicare Part D prescription drug program more broadly, to other areas of Medicare.
He cited Medicare Part B, which covers drugs that are purchased and administered by physicians rather than obtained by beneficiaries with a doctor's prescription.
[Click the title, above, to post a comment.]


Post a Comment

Please do not give advice. We can best help each other by telling what works for us, not what we think someone else should do.